News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The preliminary scientific program of ESHCML2024 is available
Photo from ESH/X
Aug 28, 2024, 04:46

The preliminary scientific program of ESHCML2024 is available

The European School of Haematology (ESH) shared on X:

“The preliminary scientific program of ESHCML2024 is available! Read it and register here.

ESH-ICMLF 26th annual John Goldman conference on CML, September 27-29, 2024 in Prague.

Chairs: Jorge Cortes, Tim Hughes, D. S. Krause

Source: ESH/X

cancer CML D. S. Krause ESH-ICMLF 26th annual John Goldman conference ESHCML2024 Jorge Cortes OncoDaily Oncology Tim Hughes
Special Coverage
Blog
Aug 3, 2025, 14:23
Luis E Raez: Best of ASCO Conference in Miami
Career
Aug 3, 2025, 14:21
Mei Ling Yap is the Recipient of the 2025 Jeannie Ferris Award
Science
Aug 3, 2025, 14:05
Alessandro Di Federico: Clinicogenomic Features of Pulmonary Sarcomatoid Carcinoma
Science
Aug 3, 2025, 12:58
Stephen V Liu: Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
Blog
Aug 3, 2025, 12:56
Pavlos Msaouel: Adaptive Subgroup Clustering for Personalized Dosing and Improved Outcomes
Insight
Aug 3, 2025, 12:33
New Integrative Oncology eBook by Society for Integrative Oncology and CancerChoices
Blog
Aug 3, 2025, 12:31
Eric Singhi: Long Term Safety Follow-Up with RET Inhibitors
Blog
Aug 3, 2025, 12:29
Chrystal Paulos: Honored to Be Awarded the All-Star V Foundation grant
Science
Aug 3, 2025, 12:23
Al-Ola A Abdallah: Why I Believe China is Bypassing the U.S. in Cellular Therapy Innovation
Science
Aug 3, 2025, 12:15
Shankar Siva: SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma
Blog
Aug 3, 2025, 12:13
Sarah Louden: ASCO Direct 2025 in Denver 
Blog
Aug 3, 2025, 12:05
Benjamin Ebert: With Every Mile, Dana-Farber is Closer to Changing the Future of Cancer Treatment